Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
2-(5-Methyl-1,2,4-oxadiazol-3-yl)propan-2-amine → 5-Cyclopropyl-N-(2-(5-methyl-1,2,4-oxadiazol-3-yl)propan-2-yl)-6-((tetrahydro-2H-pyran-4-yl)methoxy)picolinamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 2-(5-Methyl-1,2,4-oxadiazol-3-yl)propan-2-amine | HCID 43559251 | — |
| 반응물 | 5-Cyclopropyl-6-(tetrahydro-furan-2-ylmethoxy)-pyridine-2-carboxylic acid | HCID 71087254 | — |
| 반응물 | 5-Cyclopropyl-6-(tetrahydro-pyran-4-ylmethoxy)-pyridine-2-carboxylic acid | HCID 71087560 | — |
| 생성물 | 5-Cyclopropyl-N-(2-(5-methyl-1,2,4-oxadiazol-3-yl)propan-2-yl)-6-((tetrahydro-2H-pyran-4-yl)methoxy)picolinamide | HCID 71087723 | — |
반응 단계
The title compound was synthesized in analogy to Example 1, using 5-cyclopropyl-6-(tetrahydro-pyran-4-ylmethoxy)-pyridine-2-carboxylic acid (which can e.g. be prepared in a similar manner than 5-cyclopropyl-6-(tetrahydro-furan-2-ylmethoxy)-pyridine-2-carboxylic acid (Example 166 b)) and α,α,5-trimethyl-1,2,4-oxadiazole-3-methanamine (CAN 1153831-97-0) as starting materials, MS (EI): m/e=401.2 [M+H]+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09321727B2 |
| 출처 데이터셋 | uspto-grants-2016_04 |
| ORD ID | ord-1091fe236efe4dfa816bdab656084397 |
| 출처 메모 | uspto-grants-2016_04 |